astragaloside a has been researched along with Sleep Apnea, Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, XH; Chen, JK; Chen, LQ; Guo, MK; Li, JQ; Li, L; Su, SM | 1 |
| Chen, Y; Han, M; Jiang, S; Jiao, G; Liu, W; Wang, X | 1 |
2 other study(ies) available for astragaloside a and Sleep Apnea, Obstructive
| Article | Year |
|---|---|
Astragaloside IV ameliorates intermittent hypoxia-induced inflammatory dysfunction by suppressing MAPK/NF-κB signalling pathways in Beas-2B cells.
Topics: Cells, Cultured; Humans; Hypoxia; Inflammation; Lung; MAP Kinase Signaling System; NF-kappaB-Inducing Kinase; Protein Serine-Threonine Kinases; Respiratory Mucosa; Saponins; Sleep Apnea, Obstructive; Triterpenes | 2020 |
Astragaloside IV attenuates chronic intermittent hypoxia-induced myocardial injury by modulating Ca
Topics: Animals; Apoptosis; Calcium; Echocardiography; Fibrosis; Heart; Homeostasis; Hypoxia; Male; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Saponins; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sleep Apnea, Obstructive; Triterpenes | 2020 |